Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma

NCT00932698 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed and Refractory Multiple Myeloma

Interventions

DRUG: Ixazomib

Sponsor

Millennium Pharmaceuticals, Inc.